Quick Answer
Chemours Co reported Research And Development Expense of $108.00 million for the year ending 2025.
- Chemours Co showed a decrease of -0.9% in Research And Development Expense from 2024 to 2025.
- This data is from Chemours Co's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $40.00 million | Q3 2014: $33.00 million | Q1 2015: $23.00 million | Q2 2015: $27.00 million | Q3 2015: $18.00 million | Q1 2016: $23.00 million | Q2 2016: $17.00 million | Q3 2016: $19.00 million | Q1 2017: $19.00 million | Q2 2017: $21.00 million | Q3 2017: $20.00 million | Q1 2018: $20.00 million | Q2 2018: $20.00 million | Q3 2018: $20.00 million | Q1 2019: $22.00 million | Q2 2019: $19.00 million | Q3 2019: $20.00 million | Q1 2020: $24.00 million | Q2 2020: $20.00 million | Q3 2020: $22.00 million | Q1 2021: $24.00 million | Q2 2021: $27.00 million | Q3 2021: $27.00 million | Q1 2022: $30.00 million | Q2 2022: $25.00 million | Q3 2022: $32.00 million | Q1 2023: $26.00 million | Q2 2023: $28.00 million | Q3 2023: $28.00 million | Q1 2024: $28.00 million | Q2 2024: $26.00 million | Q3 2024: $29.00 million | Q1 2025: $27.00 million | Q2 2025: $28.00 million | Q3 2025: $26.00 million.
- Over the full 13 years of available data (2013 to 2025), Chemours Co's Research And Development Expense has declined by 34.1%.
- Historical annual values: Fiscal year 2025: $108.00 million | Fiscal year 2024: $109.00 million | Fiscal year 2023: $108.00 million | Fiscal year 2022: $118.00 million | Fiscal year 2021: $107.00 million | Fiscal year 2020: $93.00 million | Fiscal year 2019: $80.00 million | Fiscal year 2018: $82.00 million | Fiscal year 2017: $81.00 million | Fiscal year 2016: $81.00 million | Fiscal year 2015: $97.00 million | Fiscal year 2014: $143.00 million | Fiscal year 2013: $164.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: